Enter the MedStartr Launchathon — Aug 1–Oct 6 in NYC
< Back to companies
Galen AI

Galen AI

AI healthcare companion for informed patients

Mountain View, CA, US

Galen AI is a personal AI healthcare agent that unifies medical data from clinical records and wearable devices. It provides AI-powered health insights, medication interaction alerts, 24/7 on-demand medical support, and features like lab result explanations and lifestyle tracking.

Source: Y Combinator
Get Involved in Galen AI
Claim This Profile →

How We Help

Problem Statement

Individuals face challenges in managing fragmented medical data and accessing personalized, continuous health insights and support.

Core Technology

Personal AI healthcare agent that unifies medical data from clinical records and wearable devices.

Key Differentiators

Unifies medical records from 80,000+ hospitals and labs, spanning 12,000+ locations in the US, UK, and Canada; Integrates with 20+ wearable devices including Apple Watch, Fitbit, and Dexcom; Provides AI-powered health insights; Medication interaction alerts; 24/7 on-demand medical support; Lab result explanations and interpretation; Recovery guidance for injuries and healing; Lifestyle tracking for sleep, stress, nutrition, and movement; Early trend identification and risk assessment; HIPAA-compliant with end-to-end encryption for data in transit and at rest; No data sharing with third parties with user-controlled data connections

Clinical Focus

Patient Engagement; Care Coordination; Medical Decision Support

Company Info

Business Model
B2C Subscription
Founded
2025
Total Funding
500,000
Website
galenai.com

Categories

Telehealth/Virtual Care

Disease Areas

Technologies

AIWearablesMobile ApplicationMachine LearningNLPClinical Trial SoftwareData Analytics

Clinical & IP

🔬

Clinical Validation

Pre-clinical stage. Currently in beta (pre-public release). No FDA clearance sought as the platform is a clinical decision support tool rather than a diagnostic device. Publicly available research shows AI-powered health monitoring improves chronic disease outcomes (73% of interventions based on biosignal data showed improvement vs. standard care).

MedStartr Index Score

?
29

What do you think of Galen AI?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Get Involved in Galen AI